Loading the player...
Information
Paradigm shift in lung cancer treatment
Length: :50:34
Paradigm shift in lung cancer treatment
Peter Baik, DO, FACOS, FACS
Learning Objectives:
- Outline the major clinical trials regarding neoadjuvant chemoimmunotherapy in treatment of lung cancer.
- Illustrate the implication of the major clinical trials.
- Share the different lung cancer treatment options
Dr. Baik has no disclosures.
Accreditation
The Arizona Osteopathic Medical Association (AOMA) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians.
The AOMA designates this activity for a maximum of .75 hours of AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician's participation in this activity.
The Arizona Osteopathic Medical Association (AOMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The AOMA designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AOMA Grievance Policy: The Arizona Osteopathic Medical Association strives to provide continuing medical education programs that fulfill the needs of attendees and meet the requirements of AOA Accreditation and ACCME Accreditation. Comments, questions, or complaints should be submitted in writing to Teresa Roland, Director of Education, by mail to AOMA, 3039 W. Peoria Ave, Suite C102-158, Phoenix, AZ 85029, or email teresa@azosteo.org.
Peter U Baik, DO
Dr. Baik attended A.T. Still University Kirksville College of Osteopathic Medicine (ATSUKCOM) in Kirksville, MO, and graduated in 2005. He underwent training at Brown University (family medicine Internship), St. Barnabas Hospital in Bronx, NY (general surgery), Arrowhead Regional Medical Center in Colton, CA (general surgery), University of Miami (cardiothoracic surgery) in FL, and at Swedish Medical Center in Seattle, WA (minimally invasive thoracic and esophageal surgery). He has been with Cancer Treatment Centers of America as a thoracic surgeon since 2014. He is a member of the American College of Osteopathic Surgeons (Chair-Elect of Cardiothoracic and Vascular Surgery Section 2019-2020), American College of Surgeons, American Society of Clinical Oncology (a member of the QOPI Steering Group), and the Society of Thoracic Surgeons. He is an adjunct assistant professor of surgery with the Oklahoma State University Center for Health Sciences College of Osteopathic Medicine (OSUCOM) in Tulsa, OK, and Arkansas College of Osteopathic Medicine in Fort Smith, AK.
